Unicorn Pharmaceuticals Inc.

We own 1) a patent for switching atorvastatin to OTC; 2) patents pending for all other "statins" using the same treatment methods; and 3) a grandfather patent

  • Stage Product In Development
  • Industry Consumer Products
  • Location Durham, NC, USA
  • Currency USD
  • Founded July 2014
  • Employees 2
  • Incorporation Type C-corp
  • Website none

Company Summary


We own: 1) a patent for switching Rx drugs to OTC for asymptomatic conditions, e.g., Lipitor, claiming a mandatory Dx before and after first drug regimen to prevent off-label sales.

Team

  • Frederic Huser
    CEO & Founder

    Former CEO Novartis Consumer Health N. America 1995 - 2000 with line responsibility for 10 nationally advertised and promoted OTC brands and over $500MM in annual sales. Also, a former Partner at the New England Consulting Group focusing on healthcare. Fred has a BA from Duke and an MBA from the Harvard Business School.

  • Robert Jones
    Board Member

    Bob Jones has over 30 years of experience in brand, generic and OTC pharmaceuticals. He currently is President, CEO, and Director of Acura Pharmaceuticals, Inc. From 2003 to 2008 Bob served first as VP Finance and then as VP Strategy and Business Analysis of Adolor Corporation. Prior to that, Bob was VP Sales and Marketing for Purepac Pharmaceuticals. Bob received his MBA from the University of North Carolina and a BS from Cornell University.

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free